Medical Breakthroughs from Penn Medicine
Recently the FDA approved a “Glowing Tumor” imaging drug to help oncologists better identify ovarian cancer cells using an approach pioneered by surgeons at Penn Medicine.
Duration: 9:29 Publish Date: 10/20/2022
Breaking Through Barriers: Meet the Minds Behind Emerging mRNA Technology
Dr. Drew Weissman, Professor of Medicine at Penn Medicine, and Dr. Katalin Karikó, biochemist and Adjunct Professor at Penn Medicine, join ReachMD to take a deep dive into the future of mRNA technology.
Duration: 10:30 Publish Date: 03/08/2022
BROADCASTMED